HeyJaredJennifer Zieba
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 3, 2026
- Outlet visibility, for LiveScience
- Top 50K sites
- Earliest in this view
- Aug 18, 2026
Latest articles
Psilocybin may protect against a common, debilitating side effect of chemotherapy, early study finds (opens the original)
Read excerpt
Chemotherapy can save lives, but for many cancer patients, it leaves behind a painful legacy: damaged nerves that burn, tingle or go numb. Now, researchers report that a psychedelic compound may protect those nerves — not through its mind-bending effects, but by helping neurons keep their internal power supplies moving. A new mouse study, published Thursday (Sept. 3) in the journal Science, suggests that psilocybin, the psychedelic compound in "magic mushrooms," may help prevent this painful and
Peptides are the latest wellness fad. What are they, and are they safe? (opens the original)
Read excerpt
Controversial wellness products called peptides are rising in popularity as they're touted by leaders like Health and Human Services Secretary Robert F. Kennedy Jr. While some peptides — including drugs like Ozempic — have been rigorously tested and approved by the Food and Drug Administration (FDA), many peptides are untested and unregulated. These untested peptides are often accessible online for anyone to purchase from loosely regulated manufacturers. There's now a multibillion-dollar gray ma
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For LiveScience, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.